Epstein–Barr virus infection and nasopharyngeal carcinoma
Epstein–Barr virus (EBV) is associated with multiple types of human cancer, including lymphoid and epithelial cancers. The closest association with EBV infection is seen in undifferentiated nasopharyngeal carcinoma (NPC), which is endemic in the southern Chinese population. A strong association betw...
Saved in:
Published in | Philosophical transactions of the Royal Society of London. Series B. Biological sciences Vol. 372; no. 1732; p. 20160270 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
The Royal Society
19.10.2017
The Royal Society Publishing |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Epstein–Barr virus (EBV) is associated with multiple types of human cancer, including lymphoid and epithelial cancers. The closest association with EBV infection is seen in undifferentiated nasopharyngeal carcinoma (NPC), which is endemic in the southern Chinese population. A strong association between NPC risk and the HLA locus at chromosome 6p has been identified, indicating a link between the presentation of EBV antigens to host immune cells and NPC risk. EBV infection in NPC is clonal in origin, strongly suggesting that NPC develops from the clonal expansion of a single EBV-infected cell. In epithelial cells, the default program of EBV infection is lytic replication. However, latent infection is the predominant mode of EBV infection in NPC. The establishment of latent EBV infection in pre-invasive nasopharyngeal epithelium is believed to be an early stage of NPC pathogenesis. Recent genomic study of NPC has identified multiple somatic mutations in the upstream negative regulators of NF-κB signalling. Dysregulated NF-κB signalling may contribute to the establishment of latent EBV infection in NPC. Stable EBV infection and the expression of latent EBV genes are postulated to drive the transformation of pre-invasive nasopharyngeal epithelial cells to cancer cells through multiple pathways.
This article is part of the themed issue ‘Human oncogenic viruses’. |
---|---|
Bibliography: | Theme issue ‘Human oncogenic viruses’ compiled and edited by Yuan Chang, Patrick S. Moore and Robin A. Weiss ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 One contribution of 14 to a theme issue ‘Human oncogenic viruses’. |
ISSN: | 0962-8436 1471-2970 1471-2970 |
DOI: | 10.1098/rstb.2016.0270 |